Biotricity Inc. (BTCY) investors see Ionic group report 9.9% ownership cap

Rhea-AI Filing Summary

Ionic Ventures LLC and affiliated reporting persons report beneficial ownership of Biotricity Inc. common stock. They are deemed to beneficially own 3,241,770 shares of Common Stock, representing 9.9% of the class, based on 29,402,934 shares outstanding as of June 20, 2026.

The position consists of 194,550 shares of common stock and up to 3,047,220 Conversion Shares issuable from Series B Convertible Preferred Stock, subject to a 9.99% beneficial ownership Blocker and limits on the number of Conversion Notices under the Certificate of Designations. Ionic Management, Brendan O'Neil, and Keith Coulston are deemed to share voting and dispositive power over the same shares.

Key Figures

Beneficially owned shares: 3,241,770 shares Ownership percentage: 9.9 % Shares outstanding: 29,402,934 shares +5 more

8 metrics

Beneficially owned shares 3,241,770 shares Shares of Biotricity common stock beneficially owned by the reporting persons

Ownership percentage 9.9 % Percentage of Biotricity common stock class beneficially owned

Shares outstanding 29,402,934 shares Biotricity common stock outstanding as of June 20, 2026

Direct common shares held 194,550 shares Common stock directly held by Ionic Ventures

Conversion Shares counted 3,047,220 shares Common shares issuable from Preferred Stock included in beneficial ownership

Potential convertible amount $2,250,000 Preferred Stock convertible within sixty days of June 30, 2026

Maximum Conversion Shares at current price 18,145,161 shares Shares issuable from $2,250,000 Preferred Stock at $0.124 Alternate Conversion Price

Additional Conversion Shares excluded 15,097,941 shares Not deemed beneficially owned due to 9.99% Blocker

Key Terms

beneficial ownership limitation, Conversion Shares, Certificate of Designations, Alternate Conversion Price, +2 more

6 terms

beneficial ownership limitation regulatory

"subject to a 9.99% beneficial ownership limitation provision (the "Blocker")"

A beneficial ownership limitation is a rule that caps the percentage of a company’s shares an investor can be treated as owning or controlling for voting, regulatory or tax purposes. It matters to investors because it can restrict how many shares a person or group can buy or vote, affect takeover chances, and influence share liquidity and value — like a speed limit that prevents any single driver from taking over the whole road.

Conversion Shares financial

"an aggregate of up to 3,047,220 shares of Common Stock (the "Conversion Shares") issuable"

Certificate of Designations regulatory

"contained in the issuer's Amended Certificate of Designations of the Preferred Stock"

A certificate of designations is a formal legal document that spells out the specific rights and rules attached to a particular class of stock, most often preferred shares. It tells investors who gets paid first, what dividends or conversion rights exist, and any voting or liquidation priorities—like an instruction sheet that decides which shareholders get preference if a company pays out or is sold. Those terms directly affect a security’s value and risk.

Alternate Conversion Price financial

"based on an Alternate Conversion Price (as defined in the Certificate of Designations) of $0.124 per share"

Conversion Notices regulatory

"limitation imposed on the number of Conversion Notices (as defined in the Certificate of Designations)"

Alternate Conversion Measuring Period financial

"based on the five-day Alternate Conversion Measuring Period (as defined in the Certificate of Designations)"

FAQ

How much of Biotricity Inc. (BTCY) stock do the reporting persons beneficially own?

The reporting persons beneficially own 3,241,770 shares of Biotricity common stock, representing 9.9% of the outstanding class, based on 29,402,934 shares outstanding as of June 20, 2026, as disclosed in the company’s Form 10-K.

What makes up the 3,241,770 shares owned in Biotricity Inc. (BTCY)?

The 3,241,770 shares consist of 194,550 common shares held by Ionic Ventures and up to 3,047,220 Conversion Shares issuable from Series B Convertible Preferred Stock, subject to the 9.99% beneficial ownership Blocker in the Certificate of Designations.

What is the 9.99% Blocker mentioned in the Biotricity Inc. (BTCY) Schedule 13G/A?

The 9.99% Blocker limits conversions of Preferred Stock so the holder and its affiliates cannot beneficially own more than 9.99% of Biotricity’s common stock immediately after conversion, as set out in the Certificate of Designations.

How many Biotricity Inc. (BTCY) shares could the Preferred Stock convert into under current terms?

Within sixty days of June 30, 2026, up to $2,250,000 of Preferred Stock is convertible into 18,145,161 shares of common stock at an Alternate Conversion Price of $0.124 per share, though most are not deemed beneficially owned due to the Blocker and notice limits.

Who are the reporting persons in the Biotricity Inc. (BTCY) Schedule 13G/A Amendment No. 8?

The reporting persons are Ionic Ventures LLC, Ionic Management, LLC, and individuals Brendan O'Neil and Keith Coulston. They are deemed to share voting and dispositive power over 3,241,770 Biotricity shares beneficially owned through Ionic Ventures.

What additional Biotricity Inc. (BTCY) shares are not deemed beneficially owned by Ionic?

An additional 15,097,941 Conversion Shares and 8,870,967 Conversion Shares (from $1,100,000 of Preferred Stock at $0.124 per share) are not deemed beneficially owned due to the 9.99% Blocker and limits on the number of Conversion Notices within sixty days of June 30, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/14/2026 - 04:12 PM Accepted by SEC EDGAR 08/14/2026 - 04:05 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 8)

BIOTRICITY INC.

(Name of Issuer)

Common Stock, par value $0.001 per share

(Title of Class of Securities)

09074H203

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 09074H203

1

Names of Reporting Persons

Ionic Ventures, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

CALIFORNIA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 3,241,770.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 3,241,770.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,241,770.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.9 %

12

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person: As more fully described in Item 4 of this Amendment No. 8 to Statement on Schedule 13G (this ''Amendment No. 8''), such shares and percentage are based on 29,402,934 shares of the common stock, par value $0.001 per share, of the issuer (the ''Common Stock'') outstanding as of June 20, 2026, as disclosed in the issuer's Annual Report on Form 10-K for the fiscal year ended March 31, 2026, filed by the issuer with the U.S. Securities and Exchange Commission (''SEC'') on July 14, 2026 (the ''Form 10-K''). Ownership consists of (i) 194,550 shares of Common Stock held by the reporting person and (ii) an aggregate of up to 3,047,220 shares of Common Stock (the ''Conversion Shares'') issuable upon conversion of shares of Series B Convertible Preferred Stock, par value $0.001 per share, of the issuer (the ''Preferred Stock'') directly held by the reporting person, further conversions of which are subject to a 9.99% beneficial ownership limitation provision (the ''Blocker'') contained in the issuer's Amended Certificate of Designations of the Preferred Stock (the ''Certificate of Designations'').

SCHEDULE 13G

CUSIP Number(s): 09074H203

1

Names of Reporting Persons

Ionic Management, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 3,241,770.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 3,241,770.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,241,770.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.9 %

12

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person: As more fully described in Item 4 of this Amendment No. 8, such shares and percentage are based on 29,402,934 shares of Common Stock outstanding as of June 20, 2026, as disclosed in the Form 10-K. Ownership consists of (i) 194,550 shares of Common Stock indirectly held by the reporting person and (ii) an aggregate of up to 3,047,220 Conversion Shares issuable upon conversion of shares of Preferred Stock indirectly held by the reporting person, further conversions of which are subject to the Blocker contained in the Certificate of Designations.

SCHEDULE 13G

CUSIP Number(s): 09074H203

1

Names of Reporting Persons

Brendan O'Neil

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 3,241,770.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 3,241,770.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,241,770.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.9 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: As more fully described in Item 4 of this Amendment No. 8, such shares and percentage are based on 29,402,934 shares of Common Stock outstanding as of June 20, 2026, as disclosed in the Form 10-K. Ownership consists of (i) 194,550 shares of Common Stock indirectly held by the reporting person and (ii) an aggregate of up to 3,047,220 Conversion Shares issuable upon conversion of shares of Preferred Stock indirectly held by the reporting person, further conversions of which are subject to the Blocker contained in the Certificate of Designations.

SCHEDULE 13G

CUSIP Number(s): 09074H203

1

Names of Reporting Persons

Keith Coulston

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 3,241,770.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 3,241,770.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,241,770.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.9 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: As more fully described in Item 4 of this Amendment No. 8, such shares and percentage are based on 29,402,934 shares of Common Stock outstanding as of June 20, 2026, as disclosed in the 10-K. Ownership consists of (i) 194,550 shares of Common Stock indirectly held by the reporting person and (ii) an aggregate of up to 3,047,220 Conversion Shares issuable upon conversion of shares of Preferred Stock indirectly held by the reporting person, further conversions of which are subject to the Blocker contained in the Certificate of Designations.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: BIOTRICITY INC.
(b)	Address of issuer's principal executive offices: 203 Redwood Shores Parkway, Suite 600, Redwood City, California 94065
Item 2.
(a)	Name of person filing: (i) Ionic Ventures LLC, a California limited liability company ("Ionic"); (ii) Ionic Management, LLC, a Delaware limited liability company ("Ionic Management"); (iii) Brendan O'Neil ("Mr. O'Neil"); and (iv) Keith Coulston ("Mr. Coulston"). The foregoing persons are hereinafter collectively referred to as the "Reporting Persons". Any disclosures herein with respect to persons other than the Reporting Persons are made on information and belief after making inquiry to the appropriate party. The Reporting Persons have entered into a Joint Filing Agreement, a copy of which is filed as Exhibit 1 to the Statement on Schedule 13G filed by the Reporting Persons with the SEC on August 8, 2024 (the "Schedule 13G"), pursuant to which such Reporting Persons have agreed to file this Amendment No. 8 and all subsequent amendments to the Schedule 13G, Amendment No. 1 to the Schedule 13G, filed by the Reporting Persons with the SEC on November 14, 2024 ("Amendment No. 1"), Amendment No. 2 to the Schedule 13G, filed by the Reporting Persons with the SEC on February 4, 2025 ("Amendment No. 2"), Amendment No. 3 to the Schedule 13G, filed by the Reporting Persons with the SEC on May 15, 2025 ("Amendment No. 3"), Amendment No. 4 to the Schedule 13G, filed by the Reporting Persons with the SEC on August 12, 2025 ("Amendment No. 4"), Amendment No. 5 to the Schedule 13G, filed by the Reporting Persons with the SEC on November 14, 2025 ("Amendment No. 5"), Amendment No. 6 to the Schedule 13G, filed by the Reporting Persons with the SEC on February 4, 2026 ("Amendment No. 6"), and Amendment No. 7 to the Schedule 13G, filed by the Reporting Persons with the SEC on May 12, 2026 ("Amendment No. 7" and, together with Amendment No. 1, Amendment No. 2, Amendment No. 3, Amendment No. 4, Amendment No. 5, and Amendment No. 6, the "Amendments") jointly in accordance with the provisions of Rule 13d-1(k) of the Act. The filing of this Amendment No. 8 should not be construed in and of itself as an admission by any Reporting Person as to beneficial ownership of the shares of Common Stock reported herein.
(b)	Address or principal business office or, if none, residence: The principal business address of each of the Reporting Persons is 3053 Fillmore St, Suite 256, San Francisco, CA 94123.
(c)	Citizenship: Ionic is a limited liability company organized under the laws of the State of California. Ionic Management is a limited liability company organized under the laws of the State of Delaware. Each of Mr. O'Neil and Mr. Coulston is a citizen of the United States.
(d)	Title of class of securities: Common Stock, par value $0.001 per share
(e)	CUSIP No.: 09074H203
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: This Amendment No. 8 amends and supplements the Schedule 13G, as amended and supplemented by the Amendments. The purpose of this Amendment No. 8 is to update the beneficial ownership information on the cover pages and in Item 4 in each of the Schedule 13G and the Amendments. The information required by this item with respect to each Reporting Person is set forth in Rows 5 through 9 and 11 of the cover pages to this Amendment No. 8 and is incorporated herein by reference for each such Reporting Person. The ownership percentages reported are based on (i) 29,402,934 shares of Common Stock outstanding as of June 20, 2026, as disclosed in the Form 10-K, and (ii) up to 3,047,220 shares of Common Stock issuable upon conversion of shares of the Preferred Stock held by Ionic, further conversions of which are subject to the 9.99% Blocker contained in the Certificate of Designations. Ionic holds (i) 194,550 shares of Common Stock and (ii) 335 shares of Preferred Stock. Pursuant to the terms of the Certificate of Designations, within sixty days of the last date of the period to which this Amendment No. 8 relates, up to an aggregate of $2,250,000 of such shares of Preferred Stock are convertible into up to 18,145,161 shares of Common Stock, based on an Alternate Conversion Price (as defined in the Certificate of Designations) of $0.124 per share as of June 30, 2026, of which 15,097,941 Conversion Shares are not deemed beneficially owned by Ionic as a result of the triggering of the 9.99% Blocker contained in the Certificate of Designations, which prohibits Ionic from converting its shares of Preferred Stock into Conversion Shares if, as a result of such conversion, the holder, together with its affiliates and any persons acting as a group together with such holder or any of such affiliates, would beneficially own more than 9.99% of the total number of shares of Common Stock then issued and outstanding immediately after giving effect to such conversion. In addition, an aggregate of $1,100,000 of shares of Preferred Stock convertible into 8,870,967 Conversion Shares (based on an Alternate Conversion Price of $0.124 per share) are not deemed beneficially owned by Ionic as a result of the limitation imposed on the number of Conversion Notices (as defined in the Certificate of Designations) that may be delivered by Ionic within sixty days of June 30, 2026 based on the five-day Alternate Conversion Measuring Period (as defined in the Certificate of Designations). Consequently, Ionic is the beneficial owner of 3,241,770 shares of Common Stock (the "Shares"). Ionic has the power to dispose of and the power to vote the Shares beneficially owned by it, which power may be exercised by its manager, Ionic Management. Each of the managers of Ionic Management, Mr. O'Neil and Mr. Coulston, has shared power to vote and/or dispose of the Shares beneficially owned by Ionic and Ionic Management. Neither Mr. O'Neil nor Mr. Coulston directly owns the Shares. By reason of the provisions of Rule 13d-3 of the Act, each of Mr. O'Neil and Mr. Coulston may be deemed to beneficially own the Shares which are beneficially owned by each of Ionic and Ionic Management, and Ionic Management may be deemed to beneficially own the Shares which are beneficially owned by Ionic.
(b)	Percent of class: (A) Ionic: 9.99 % (B) Ionic Management: 9.99 % (C) Mr. Coulston: 9.99 % (D) Mr. O'Neil: 9.99 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: (A) Ionic: 0.00 (B) Ionic Management: 0.00 (C) Mr. Coulston: 0.00 (D) Mr. O'Neil: 0.00
	(ii) Shared power to vote or to direct the vote: (A) Ionic: 3,241,770 (B) Ionic Management: 3,241,770 (C) Mr. Coulston: 3,241,770 (D) Mr. O'Neil: 3,241,770
	(iii) Sole power to dispose or to direct the disposition of: (A) Ionic: 0.00 (B) Ionic Management: 0.00 (C) Mr. Coulston: 0.00 (D) Mr. O'Neil: 0.00
	(iv) Shared power to dispose or to direct the disposition of: (A) Ionic: 3,241,770 (B) Ionic Management: 3,241,770 (C) Mr. Coulston: 3,241,770 (D) Mr. O'Neil: 3,241,770
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to §240.13d-1(c) or §240.13d-1(d), attach an exhibit stating the identity of each member of the group. See Exhibit 1 filed with the Schedule 13G.
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Ionic Ventures, LLC

Signature:	/s/ Keith Coulston
Name/Title:	Keith Coulston, Manager of Ionic Management, LLC, Manager of Ionic Ventures, LLC
Date:	08/14/2026

Ionic Management, LLC

Signature:	/s/ Keith Coulston
Name/Title:	Keith Coulston, Manager
Date:	08/14/2026

Brendan O'Neil

Signature:	/s/ Brendan O'Neil
Name/Title:	Brendan O'Neil
Date:	08/14/2026

Keith Coulston

Signature:	/s/ Keith Coulston
Name/Title:	Keith Coulston
Date:	08/14/2026

Comments accompanying signature: LIST OF EXHIBITS Exhibit No. 1 - Joint Filing Agreement, dated August 8, 2024 (incorporated by reference to Exhibit 1 to the Schedule 13G filed by the Reporting Persons with the SEC on August 8, 2024).